NEW YORK, Dec. 18, 2024 /PRNewswire/ — Compliancy Group has been awarded as G2’s Winter Leader for Healthcare Compliance Software.
As a Winter 2024 Leader, Compliancy Group was rated number one for HIPAA Compliance, Auditing & Risk Assessment, BAA Management. Compliancy Group is also in the Healthcare Risk Management category, rated as number one for templates, education, incident management, report generation, and user satisfaction.
Compliancy Group was also recognized as:
To qualify for inclusion in the Healthcare Compliance category, a product must:
Learn more about what real users have to say (or leave your own review of Compliancy Group) on G2’s Compliancy Group review page!
Healthcare Compliance Resources
Healthcare Compliance Guide
HIPAA Checklist
Meeting OSHA Requirements in Healthcare
About Compliancy Group
Solve healthcare compliance challenges quickly and confidently with simplified software. Compliancy Group offers a robust toolset to track and manage all your healthcare compliance requirements with customizable software. Get an overview of your compliance readiness and easily generate reports to prove your compliance efforts. Expedite incident reporting and response management, record all the efforts, and identify organizational risk with a complete set of ticketing, tracking, and analysis tools.
Remove the complexities and stress of compliance, increase patient loyalty and the profitability of your business, and reduce risk. Endorsed by top medical associations, clients can be confident in their compliance program. Learn more about Compliancy Group and healthcare compliance!
About G2
G2 is the world’s largest and most trusted software marketplace. More than 80 million people annually — including employees at all of the Fortune 500 — use G2 to make smarter software decisions based on authentic peer reviews. Thousands of software and services companies of all sizes partner with G2 to build their reputation, manage their software spend, and grow their business – visit www.g2.com.
CONTACT: Lauren Vetter, info@compliancygroup.com
SOURCE Compliancy Group
CAMBRIDGE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader…
Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel treatments targeting STAT3 to…
TORONTO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Redecan Cannabis, a leading brand under Tilray Brands,…
Company debt reduced by $194 millionCash position after closing will be in excess of $180…
ALK’s peanut tablet shown to be safe and tolerable across multiple doses.Development now advances to…
Investments of up to $50 million from the Bill & Melinda Gates Foundation to develop…